Health
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs
Avance Clinical streamlines its biotech clients' clinical trial operations, workflows, and data management, optimizing study efficiencies,minimizing costs, and accelerating trial timelines. SAN ANTONIO, Aug. 27, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the biotech contract researc...
2024-08-27 11:30
1297
2024 TPI Day Convenes Expert Views on Sustainability, Open Source and AI
TAIPEI, Aug. 27, 2024 /PRNewswire/ -- TPIsoftware hosts its annual forum TPI Day in collaboration with Taipei Medical Alliance and multinational open-source software company SUSE to foster insightful dialogues on industry trends: Sustainability, Open Source and Artificial Intelligence (AI). Held ...
2024-08-27 11:11
608
ArkBio Presented at the 8th Annual IPF Summit and Announced Completion of Patient Enrollment for Phase 2 Clinical Trial of AK3280, a Next-Generation Drug for IPF Treatment
BEIJING, Aug. 27, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a privately held, clinical-stage biopharmaceutical company today announced that Dr.Jim Wu, Chief Executive Officer of ArkBio, gave an oral presentation entitled"Development of Next Generation Broadly Activ...
2024-08-27 09:00
1704
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI TOKYO, Aug. 27, 2024 /PRNewswire/ -- Fujitsu today announced that it will begin initiatives to attract global clinical trials toJapan and tackle the 'drug loss' issue by working with pharma...
2024-08-27 08:07
1696
Experts Agree On the Longevity of EMFACE's Non-Invasive Face-Lifting Effects
PRAGUE, Aug. 27, 2024 /PRNewswire/ -- Continuous research by Dr. Yael Halaas (
USA) and Dr. Woraphong Manuskiatti (Thailand) has unveiled the first evidence
on the longer-term effectiveness of EMFACE
2024-08-27 08:00
2264
Telix Announces Reorganisation to Deliver on Strategic Priorities
MELBOURNE, Australia, Aug. 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces new leadership appointments as part of an internal reorganisation to align its operations across four business units, reflecting its focus as a therapeutics-led radiop...
2024-08-27 07:15
1701
Kaiyi Healthcare: Pioneering Medical Innovation, Deepening Brand Essence, and Shaping a Healthier Future Together
SHANGHAI, Aug. 27, 2024 /PRNewswire/ -- Recently, Kaiyi Healthcare has made significant strides across its network of hospitals. In July, Wuxi Kaiyi Hospital launched a new emergency response substation connected toChina's '120' emergency medical services (EMS)—a system akin to '911' in the US or...
2024-08-27 07:00
1837
TraceLink Becomes First Solution Provider to Secure All 16 GS1 US Conformance Trustmarks for EPCIS File Support
BOSTON, Aug. 26, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, proudly announces it has become the first and only solution provider to secure all 16 GS1 US Conformance Trustmarks for ...
2024-08-26 23:31
1432
About Circul VS: A Core Continuous Blood Pressure Measurement Technology System Developed in Partnership with Dr. Ehud Baron
SHENZHEN, China, Aug. 26, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is excited to announce its collaboration on Circul VS, a core continuous blood pressure measurement technology system developed in partnership with strategic partner, Dr.Ehud Baron. Designed to o...
2024-08-26 21:25
2194
World-Renowned Scientist Wah Chiu, Stanford University Professor and Honorary Advisor to Pohang City, visited Korea at the invitation of the Coree Group
- Seminar presentation at the invitation of Dx&Vx and Coree Group SEOUL, South Korea, Aug. 26, 2024 /PRNewswire/ -- Professor Wah Chiu, who visited Korea at the invitation of the Coree Group, led by ChairmanLim Chong Yoon, an inside director of Hanmi Pharmaceutical and the largest shareholder of ...
2024-08-26 21:00
1972
Seegene Develops mpox PCR Test Assays following the WHO Global Health Emergency Declaration
- Develops NovaplexTM MPXV/OPXV Assay and NovaplexTM HSV-1&2/VZV/MPXV Assay - Designed to detect four viruses at once using multiplex PCR technology - Utilize dual internal controls to ensure highly reliable test results - Pledges to supply assays meeting the needs of respective countries SE...
2024-08-26 21:00
2074
Australian Brand Witsbb Upgrades Its Health Focus After Years in the Maternal and Child Nutrition Sector, Offering Better Care for Babies
SYDNEY, Aug. 26, 2024 /PRNewswire/ -- Recently, Australian company FORESTPARK announced that its brand Witsbb's core products, including Vitamin AD and the Non-allergenic Liquid Calcium, have been tested by an authoritative third-party quality inspection company and found to be free from dozens o...
2024-08-26 15:46
1620
CStone Reports 2024 Interim Results and Recent Corporate Updates
* Total revenue of RMB 254.2 million for 2024 H1; achieving first-time profitability with cash reserve atRMB 814 million as of June 30, 2024. * NDA approval of sugemalimab (PD-L1) for Stage IV NSCLC in EU, marking the first successful international approval of aChina domestic anti-PD-L1 mAb. ...
2024-08-23 22:20
6737
UTime Limited to Participate in International Medical Fairs and Medical Conferences
SHENZHEN, China, Aug. 23, 2024 /PRNewswire/ -- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its plans to participate in a series of internationally recognized medical fairs and medical conferences. These forthcoming events will provide a valuable opportunity for U...
2024-08-23 21:25
5306
FINGERPRINT STUDY OF 1000 SINGAPOREANS SHOWS HIGH SELF-MANAGEMENT AND RESILIENCE TRAITS: BRILLIANAIRE
* Brillianaire's dermatoglyphic personality and potential testing uncovers major personality traits of Singaporeans across all ages * Singapore firm believes such data will help Singapore chart a better future by tapping on its strongest resource: people SINGAPORE, Aug. 23, 2024 /PRNewswire/ ...
2024-08-23 13:46
2748
Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization
SHANGHAI and HONG KONG, Aug. 23, 2024 /PRNewswire/ -- Antengene Corporation (6996.HK) today announced its interim results for the period endingJune 30, 2024 , along with several significant milestones achieved in recent months. Dr. Jay Mei, Antengene's Founder, Chairman, and CEO, stated, "In the...
2024-08-23 12:32
3742
Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market
Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States for an aggregated purchase price, including upfront and earn out payments, estimated to approximatelyUSD 477 million. GOTHENBURG, Swe...
2024-08-23 05:00
2659
Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access
CHICAGO, Aug. 23, 2024 /PRNewswire/ -- The Alzheimer's Association welcomes today's decision by theUnited Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab) for the treatment of Alzheimer's disease. However, while celebrating this milestone — the ...
2024-08-23 00:31
2984
Ascentage Pharma Announces 2024 Interim Results
ROCKVILLE, Md. and SUZHOU, China, Aug. 22, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malignancies, today announced its 2024 interim results. During ...
2024-08-22 23:36
4069
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities
MELBOURNE, Australia, Aug. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended30 June 2024. All figures are in AU$ unless otherwise stated.[1] H1 2024 financial highlights * Total Group revenue o...
2024-08-22 17:04
1929
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5214
